Wells Fargo & Company (0R2F)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 82.35 |
|---|---|
| 52-week range | 71.95 – 95.89 |
| Return, 1 month / 3 months | −1.7% / −4.1% |
| Return, 1 year / 3 years | −1.6% / +116.9% |
| Trend | Below its 200-day average |
| RSI (14) | 48 |
| Volatility (1 year) | 25.7% |
| Worst drawdown (1 year) | -23.5% |
| Average daily value traded | 0.90M USD |
| Dividend yield | 2.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Wells Fargo & Company is an American bank based in San Francisco that serves consumers, small businesses and large corporations. It offers checking and savings accounts, credit cards, home mortgages, personal loans and investment and wealth management services. Customers use its branch network, ATMs and online and mobile banking, while its commercial arm provides lending, treasury and payment services to businesses. The bank also runs a brokerage and retirement business for individual investors.
On this site Wells Fargo & Company appears as a stock on the London Exchange (UK), code 0R2F, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Wells Fargo & Company (0R2F) trades on the London Exchange in UK. It last closed at USD 82.35 on 21 October 2026.
Its price-based Market X-Ray is 56 out of 100 (a fair price profile), ranking 1,667 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.6% and over the last three months it fell 4.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 51 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.4% | ||
| From 52-week high | -13.5% | ||
| Momentum | 44 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.1% | ||
| 6-month return | 1.7% | ||
| 12-month return, skipping the last month | 0.1% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.5% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.90M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 74 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.2% | ||
| Years with dividends | 6 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | −1.7% |
| 3 months | −4.1% |
| 6 months | +1.7% |
| 1 year | −1.6% |
| 3 years | +116.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 84.91 / 83.55 |
|---|---|
| Golden / death cross (60 days) | Golden, 52 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 2.52 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Aug 2026 | USD 0.5000 |
| 8 May 2026 | USD 0.4500 |
| 6 Feb 2026 | USD 0.4500 |
| 7 Nov 2025 | USD 0.4500 |
| 8 Aug 2025 | USD 0.4500 |
| 9 May 2025 | USD 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.